Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q3 2022 call → NOWe need to determine if the transcript describes a situation where the company is currently living through a defined waiting period it is paying for out of its own pocket, with a specific near-dated event at the end, and management conveys this as the main current work. Key points from transcript: - VITAS has a hiring and retention bonus program effective July 1, 2022. The total estimated 12-month forward-looking costs are approximately $38 million. These are one-time retention bonuses that vest after 12 months of continuous employment. So the company is paying for these bonuses (accruing costs) but the benefit (retention of staff) is expected to come over time. However, the bonuses are paid after 12 months, so the cost is being incurred now? Actually, the bonuses are cliff vested after 12 months, so the company is accruing the cost over the 12 months? The transcript says "The total estimated 12-month forward-looking costs in this program, including payroll taxes and government-mandated overtime calculations, will be approximately $38 million." So they are incurring this cost over the next 12 months. The benefit is retaining staff, which is already happening? They expanded staff by 172 employees. So they are paying for retention bonuses to keep staff, but the staff are already working and producing? The benefit is not that they are not yet earning; the staff are already providing care. So this is more like an incentive to retain employees, which is a normal operating cost? But the program is specifically to address the shortage of licensed health care professionals. The cost is real and current, but the benefit is that they retain staff, which allows them to increase capacity. However, the transcript says "This is the first significant expansion of our clinical workforce and related patient capacity since the pandemic began." So they are hiring more staff, and the cost of the bonuses is being incurred now, but the benefit of having more staff is that they can take more patients. But are they currently not earning from these staff? They are hiring staff, and those staff are working and caring for patients, so they are earning revenue from them. The waiting period might be that the new hires need time to become productive? But the transcript says they expanded staff by 172 employees, and they are seeing improvement in admissions.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.